Literature DB >> 10730021

Pharmaceutical care for patients with chronic conditions.

L R Fischer1, L M Scott, D M Boonstra, T A DeFor, S Cooper, M A Elkema, K A Hase, F Wei.   

Abstract

OBJECTIVE: To assess factors associated with participation in pharmaceutical care and the benefits of participation--in terms of amount of information about medications, administration of medications, and awareness of side effects.
DESIGN: Quasi-experimental design, with a control group. Medication Survey, administered 6 months after pharmaceutical care intervention to participants, refusers, and controls. Logistic regression analyses.
SETTING: Three staff clinic pharmacies and three contract clinic pharmacies affiliated with a health maintenance organization (HMO). PATIENTS AND OTHER PARTICIPANTS: Patients with chronic health conditions (asthma, chronic obstructive pulmonary disease, or heart disease) enrolled at six intervention sites, identified through the HMO's electronic pharmacy database. Control sample with the same chronic health conditions, without access to pharmaceutical care (n = 210 participants, 162 refusers, and 368 controls; overall adjusted response rate = 72%). INTERVENTION: Pharmaceutical care, in the form of a comprehensive drug therapy management program. MAIN OUTCOME MEASURES: Predictors of participation, amount of information about medications, use of reminder methods, and awareness of side effects.
RESULTS: The following variables were significantly associated with the probability of participating in pharmaceutical care (P < .05): number of medications, employment, income, health status, education, and living situation. Participants were more likely than controls to say they received "a lot of information" from their pharmacist about all aspects of medications (odds ratio [OR], 1.75 to 2.68). Participants were more likely to report leaving their medication container in a visible place and using two or more reminder methods (OR, 1.87 to 1.48). There were no significant differences in the probability of missing doses. Participants were more likely to report experiencing "symptoms or problems" associated with prescription medications (OR, 1.81).
CONCLUSION: Pharmaceutical care appears to increase the information given to patients about medications, promote more effective self-administration of medications by encouraging patients to use systematic reminders, and increase awareness of medication side effects.

Entities:  

Mesh:

Year:  2000        PMID: 10730021     DOI: 10.1016/s1086-5802(16)31061-0

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  6 in total

1.  Can pharmacists influence the health-related quality of life of patients with asthma?: The New Zealand Pharmaceutical Care experience.

Authors:  N Kheir; L Emmerton; J Shaw
Journal:  J Sci Res Med Sci       Date:  2001-10

Review 2.  Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).

Authors:  Sadia Janjua; Katharine C Pike; Robin Carr; Andy Coles; Rebecca Fortescue; Mitchell Batavia
Journal:  Cochrane Database Syst Rev       Date:  2021-09-08

3.  Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients.

Authors:  Stefan Ottenbros; Martina Teichert; Romy de Groot; Fabienne Griens; Fong Sodihardjo; Michel Wensing; J J de Gier
Journal:  Int J Clin Pharm       Date:  2013-12-01

Review 4.  Over-the-counter analgesics in older adults: a call for improved labelling and consumer education.

Authors:  Christianne L Roumie; Marie R Griffin
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Theoretical model and measurement of shared decision making in web-based pharmaceutical care consultation.

Authors:  Haihong Chen; Yuqi Xiong; Zinan Zhang; Qian Zhou; Dan Wang; Xuemei Wang; Xinping Zhang
Journal:  Digit Health       Date:  2022-04-04

6.  A Survey of Canadian Pharmacists' Knowledge and Comfort in the Management of Epilepsy and Antiepileptic Drugs.

Authors:  Akshita Chandok; Sherif Hanafy Mahmoud
Journal:  J Pharm Technol       Date:  2022-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.